The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.
Chronic neuroleptic treatment induces an increase in the density of D2 dopamine receptors in the striatum. The effect of prolonged administration of haloperidol on mRNA levels of the short (D2S) and long (D2L) isoforms of the D2 dopamine receptor and the D3 dopamine receptor in different brain regions was examined. Haloperidol caused a significant rise in both D2L and D2S mRNA levels in the striatum, but had no effect on D3 mRNA levels. This rise was restricted to the striatum, showing that the effect of haloperidol on dopamine receptor mRNA is both subtype- and tissue-specific.
Fishburn
C S
CS
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
David
C
C
Carmon
S
S
Fuchs
S
S
D000818:Animals; D001483:Base Sequence; D015152:Blotting, Northern; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000378:metabolism*; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D013134:Spiperone / Q000378:metabolism
D012333:RNA, Messenger; D017448:Receptors, Dopamine D2; D013134:Spiperone; D006220:Haloperidol